DK1128819T3 - Ny kugle til styret frigivelse, fremgangsmåde til dens fremstilling og formulering med flere enheder indeholdende denne - Google Patents

Ny kugle til styret frigivelse, fremgangsmåde til dens fremstilling og formulering med flere enheder indeholdende denne

Info

Publication number: DK1128819T3
Authority: DK; Denmark
Prior art keywords: preparation; controlled release; formulation containing; multiple unit; unit formulation
Prior art date: 1998-11-11

Application number

DK99971702T

Other languages

English (en)

Inventor

Torkel Gren

Anders Ringberg

Martin Wikberg

Randy J Wald

Original Assignee

Pharmacia Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-11

Filing date

1999-11-11

Publication date

2003-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1128819(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-08-26 Priority claimed from PCT/SE1999/001463 external-priority patent/WO2000012069A1/en

1999-11-11 Application filed by Pharmacia Ab filed Critical Pharmacia Ab

2003-12-01 Application granted granted Critical

2003-12-01 Publication of DK1128819T3 publication Critical patent/DK1128819T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK99971702T 1998-11-11 1999-11-11 Ny kugle til styret frigivelse, fremgangsmåde til dens fremstilling og formulering med flere enheder indeholdende denne DK1128819T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9803871A SE9803871D0 (sv)	1998-11-11	1998-11-11	Therapeutic method and formulation
PCT/SE1999/001463 WO2000012069A1 (en)	1998-08-27	1999-08-26	Therapeutic formulation for administering tolterodine with controlled release
PCT/SE1999/002052 WO2000027364A1 (en)	1998-11-11	1999-11-11	New controlled release bead, a method of producing the same and multiple unit formulation comprising it

Publications (1)

Publication Number	Publication Date
DK1128819T3 true DK1128819T3 (da)	2003-12-01

Family

ID=20413266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99971702T DK1128819T3 (da)	1998-11-11	1999-11-11	Ny kugle til styret frigivelse, fremgangsmåde til dens fremstilling og formulering med flere enheder indeholdende denne

Country Status (40)

Country	Link
US (1)	US6911217B1 (da)
EP (1)	EP1128819B1 (da)
JP (1)	JP3616011B2 (da)
KR (1)	KR100467384B1 (da)
CN (1)	CN1169522C (da)
AP (1)	AP1323A (da)
AR (1)	AR027815A1 (da)
AT (1)	ATE247458T1 (da)
AU (1)	AU762410B2 (da)
BG (1)	BG65149B1 (da)
BR (1)	BRPI9915142B8 (da)
CA (1)	CA2350061C (da)
CZ (1)	CZ299582B6 (da)
DE (1)	DE69910604T2 (da)
DK (1)	DK1128819T3 (da)
EA (1)	EA005074B1 (da)
EE (1)	EE05232B1 (da)
ES (1)	ES2204193T3 (da)
GE (1)	GEP20022833B (da)
HK (1)	HK1040917B (da)
HR (1)	HRP20010333B1 (da)
HU (1)	HU226582B1 (da)
ID (1)	ID30039A (da)
IL (1)	IL142809A0 (da)
IS (1)	IS2370B (da)
MA (1)	MA25325A1 (da)
MY (1)	MY122195A (da)
NO (1)	NO331399B1 (da)
NZ (1)	NZ511430A (da)
OA (1)	OA11673A (da)
PL (1)	PL195780B1 (da)
PT (1)	PT1128819E (da)
RS (1)	RS49891B (da)
SE (1)	SE9803871D0 (da)
SI (1)	SI1128819T1 (da)
SK (1)	SK284758B6 (da)
TW (2)	TWI267385B (da)
UA (1)	UA57165C2 (da)
WO (1)	WO2000027364A1 (da)
ZA (1)	ZA200103575B (da)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6310103B1 (en) *	1996-07-19	2001-10-30	Bridge Pharma, Inc.	S(−)-tolterodine in the treatment of urinary and gastrointestinal disorders
US8563522B2 (en)	1997-07-08	2013-10-22	The Iams Company	Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (en) *	1998-05-12	1999-11-17	Schwarz Pharma Ag	Novel derivatives of 3,3-diphenylpropylamines
SK6412002A3 (en)	1999-11-11	2002-09-10	Pharmacia Ab	Pharmaceutical formulation containing tolterodine and its use
AU2003265680A1 (en) *	2002-08-28	2004-03-19	Pharmacia Corporation	Oral liquid tolterodine composition
US8168170B2 (en)	2002-10-03	2012-05-01	The Procter And Gamble Company	Compositions having an inner core and at least three surrounding layers
WO2004064821A1 (en) *	2003-01-22	2004-08-05	Pfizer Health Ab	Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
DE10315917A1 (de) *	2003-04-08	2004-11-18	Schwarz Pharma Ag	Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
EP2112920B1 (en)	2003-06-26	2018-07-25	Intellipharmaceutics Corp.	Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
AU2004289223B2 (en)	2003-11-04	2009-11-05	Supernus Pharmaceuticals, Inc.	Once daily dosage forms of trospium
JP4771956B2 (ja)	2003-11-04	2011-09-14	スパーナスファーマシューティカルズインコーポレイテッド	バイオアベイラビリティーエンハンサを含む第四級アンモニウム化合物の組成物
US20050152884A1 (en)	2003-12-19	2005-07-14	The Procter & Gamble Company	Canine probiotic Bifidobacteria globosum
US8877178B2 (en)	2003-12-19	2014-11-04	The Iams Company	Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en)	2003-12-19	2005-07-21	The Procter & Gamble Company	Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en)	2003-12-19	2014-11-25	The Iams Company	Canine probiotic Lactobacilli
US7785635B1 (en)	2003-12-19	2010-08-31	The Procter & Gamble Company	Methods of use of probiotic lactobacilli for companion animals
US8394409B2 (en) *	2004-07-01	2013-03-12	Intellipharmaceutics Corp.	Controlled extended drug release technology
US10624858B2 (en)	2004-08-23	2020-04-21	Intellipharmaceutics Corp	Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en)	2004-08-27	2006-03-01	KRKA, D.D., Novo Mesto	Sustained release pharmaceutical composition of tolterodine
EP1836156A1 (en) *	2005-01-10	2007-09-26	Teva Gyogyszergyar Reszvenytarsasag	Substantially pure tolterodine tartrate and process for preparing thereof
BRPI0611492B1 (pt)	2005-05-31	2021-10-13	Mars, Incorporated	Bifidobactéria probiótica felina
EP2261323A1 (en)	2005-05-31	2010-12-15	The Iams Company	Feline probiotic lactobacilli
US10064828B1 (en)	2005-12-23	2018-09-04	Intellipharmaceutics Corp.	Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2997953B1 (en)	2006-01-18	2018-12-26	Intec Pharma Ltd.	Delivery device for oral intake of an agent
LT1993559T (lt)	2006-02-03	2016-11-10	Opko Renal, Llc	Vitamino d nepakankamumo ir deficito gydymas su 25-hidroksivitaminu d2 ir 25-hidroksivitaminu d3
KR100714058B1 (ko) *	2006-02-06	2007-05-02	한국유나이티드제약 주식회사	톨테로딘 엘-주석산염의 서방형 경구투여 조성물 및 이의 제조 방법
KR20080099334A (ko) *	2006-02-24	2008-11-12	테바 파마슈티컬 인더스트리즈 리미티드	메토프로롤 숙시네이트 서방정 및 이의 제조 방법
KR20080106358A (ko) *	2006-03-21	2008-12-04	테바 파마슈티컬 인더스트리즈 리미티드	톨터로딘의 제어 방출 제형
EP1839649A1 (en) *	2006-03-31	2007-10-03	LEK Pharmaceuticals D.D.	Coated formulations for tolterodine
EP2007360B1 (en) *	2006-04-03	2014-11-26	Isa Odidi	Controlled release delivery device comprising an organosol coat
US20070248670A1 (en) *	2006-04-21	2007-10-25	Van Den Heuvel Dennie J M	Tolterodine beads
US10960077B2 (en)	2006-05-12	2021-03-30	Intellipharmaceutics Corp.	Abuse and alcohol resistant drug composition
EP2026766A1 (en)	2006-05-17	2009-02-25	Synthon B.V.	Tablet composition with a prolonged release of tamsulosin
PT3357496T (pt)	2006-06-21	2020-05-12	Opko Ireland Global Holdings Ltd	Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
JP2008007458A (ja) *	2006-06-29	2008-01-17	Freunt Ind Co Ltd	レイヤリング用核粒子とその製造方法
MX2009005478A (es)	2006-11-27	2009-08-12	Lundbeck & Co As H	Derivados de heteroarilamida.
EP2124966B1 (en)	2007-02-01	2015-09-09	IAMS Europe B.V.	Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
EP3225243A1 (en)	2007-04-25	2017-10-04	Opko Renal, LLC	Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
US8361488B2 (en)	2007-04-25	2013-01-29	Cytochroma Inc.	Methods and compositions for controlled release oral dosage of a vitamin D compound
EP2148684B1 (en)	2007-04-25	2013-01-16	Cytochroma Inc.	Method of treating vitamin d insufficiency and deficiency
CL2008001970A1 (es) *	2007-07-03	2009-03-27	Synthon Bv	Perla con un nucleo de celulosa microcristalina, un recubrimiento soluble en agua con un polimero vinil pirrolidina, una capa con tolterodina y un aglutinante, y una capa de liberacion controlada con un poliacrilato; proceso para prepararla; forma de dosificacion, util en trastornos urinarios como vejiga hiperactiva.
US8486452B2 (en)	2007-07-20	2013-07-16	Mylan Pharmaceuticals Inc.	Stabilized tolterodine tartrate formulations
US8110226B2 (en) *	2007-07-20	2012-02-07	Mylan Pharmaceuticals Inc.	Drug formulations having inert sealed cores
WO2009019599A2 (en) *	2007-08-08	2009-02-12	Themis Laboratories Private Limited	Extended release compositions comprising tolterodine
EP2187873B1 (en)	2007-08-13	2018-07-25	Abuse Deterrent Pharmaceutical Llc	Abuse resistant drugs, method of use and method of making
US20090192228A1 (en) *	2008-01-28	2009-07-30	Actavis Group Ptc Ehf	Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) *	2008-02-26	2009-08-27	Lai Felix S	Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) *	2008-04-01	2009-10-01	Pharmascience Inc.	Novel oral controlled release pharmaceutical formulations
CA2714996C (en)	2008-04-02	2020-04-07	Cytochroma Inc.	Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
WO2009140557A2 (en) *	2008-05-14	2009-11-19	Capricorn Pharma, Inc.	Modified release tolterodine formulations
US9771199B2 (en)	2008-07-07	2017-09-26	Mars, Incorporated	Probiotic supplement, process for making, and packaging
US8465770B2 (en)	2008-12-24	2013-06-18	Synthon Bv	Low dose controlled release tablet
AU2010277207B2 (en) *	2009-07-31	2014-06-26	Sun Pharmaceutical Industries Limited	Multi-layered, multiple unit pharmaceutical compositions
US10104903B2 (en)	2009-07-31	2018-10-23	Mars, Incorporated	Animal food and its appearance
WO2011061616A2 (en)	2009-11-23	2011-05-26	Micro Labs Limited	Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en)	2010-02-04	2011-08-11	Synthon Bv	Tolterodine bead
JO3112B1 (ar)	2010-03-29	2017-09-20	Ferring Bv	تركيبة دوائية سريعة التحلل
ES2643087T3 (es)	2010-03-29	2017-11-21	Ferring B.V.	Composición farmacéutica de disolución rápida
PL2552484T3 (pl)	2010-03-29	2020-06-29	Opko Ireland Global Holdings, Ltd.	Sposoby i preparaty służące do zmniejszenia poziomu hormonu przytarczyc
WO2011137054A1 (en)	2010-04-30	2011-11-03	Merck Sharp & Dohme Corp.	Novel beta 3 adrenergic receptor agonists
US20120040008A1 (en) *	2010-08-11	2012-02-16	Ashish Chatterji	Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120289560A1 (en) *	2011-05-10	2012-11-15	Theravida, Inc.	Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (el)	2011-07-27	2012-06-29	Φαρματεν Αβεε,	Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου
CN103781467B (zh)	2011-09-16	2016-08-31	辉凌公司	一种快速溶解药物组合物
US20140242158A1 (en) *	2011-09-30	2014-08-28	Astellas Pharma, Inc.	Granular Pharmaceutical Composition
AU2013289403B2 (en)	2012-07-12	2017-05-11	Ferring B.V.	Diclofenac formulations
US20140093552A1 (en) *	2012-09-20	2014-04-03	Sks Ocular, Llc	Multilayer Biodegradable Microparticles for Sustained Release of Therapeutic Agents
US20150306170A1 (en) *	2012-11-21	2015-10-29	Ferring B.V.	Composition for immediate and extended release
TW201422254A (zh)	2012-11-21	2014-06-16	Ferring Bv	用於速釋及延釋的組成物
NZ629598A (en) *	2013-03-13	2016-10-28	Advanced Bionutrition Corp	Stable bioactive substances and methods of making
KR101847947B1 (ko)	2013-03-15	2018-05-28	옵코 아이피 홀딩스 Ⅱ 인코포레이티드	안정화되고 변형된 비타민 ｄ 방출 제형
US20140275038A1 (en)	2013-03-15	2014-09-18	Inspirion Delivery Technologies, Llc	Abuse deterrent compositions and methods of use
AU2014246617A1 (en)	2013-12-23	2015-07-09	Sun Pharmaceutical Industries Limited	Multi-layered, multiple unit pharmaceutical compositions
US10220047B2 (en)	2014-08-07	2019-03-05	Opko Ireland Global Holdings, Ltd.	Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10729685B2 (en)	2014-09-15	2020-08-04	Ohemo Life Sciences Inc.	Orally administrable compositions and methods of deterring abuse by intranasal administration
CA2936748C (en) *	2014-10-31	2017-08-08	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
WO2017146053A1 (ja) *	2016-02-23	2017-08-31	ニプロ株式会社	医薬組成物粒子とそれを含む口腔内崩壊製剤
MY198547A (en)	2016-03-28	2023-09-04	Opko Ireland Global Holdings Ltd	Methods of vitamin d treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1144911B (it)	1981-03-19	1986-10-29	Pharmatec Spa	Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPH07107450A (ja)	1993-10-08	1995-04-21	Hitachi Ltd	情報通信装置
JP3453186B2 (ja)	1994-04-14	2003-10-06	共和薬品工業株式会社	徐放性マイクロカプセルおよびその製造方法
SE9402422D0 (sv) *	1994-07-08	1994-07-08	Astra Ab	New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) *	1994-10-06	1997-07-08	Ortho Pharmaceutical Corporation	Multilayered controlled release pharmaceutical dosage form
US5567441A (en) *	1995-03-24	1996-10-22	Andrx Pharmaceuticals Inc.	Diltiazem controlled release formulation
US6310103B1 (en)	1996-07-19	2001-10-30	Bridge Pharma, Inc.	S(−)-tolterodine in the treatment of urinary and gastrointestinal disorders
US6312728B1 (en) *	1998-07-07	2001-11-06	Cascade Development, Inc.	Sustained release pharmaceutical preparation

1998
- 1998-11-11 SE SE9803871A patent/SE9803871D0/xx unknown
1999
- 1999-11-11 DE DE69910604T patent/DE69910604T2/de not_active Expired - Lifetime
- 1999-11-11 SI SI9930411T patent/SI1128819T1/xx unknown
- 1999-11-11 AR ARP990105734A patent/AR027815A1/es active IP Right Grant
- 1999-11-11 IL IL14280999A patent/IL142809A0/xx unknown
- 1999-11-11 AT AT99971702T patent/ATE247458T1/de active
- 1999-11-11 RS YUP-331/01A patent/RS49891B/sr unknown
- 1999-11-11 AU AU14366/00A patent/AU762410B2/en not_active Expired
- 1999-11-11 AP APAP/P/2001/002166A patent/AP1323A/en active
- 1999-11-11 ES ES99971702T patent/ES2204193T3/es not_active Expired - Lifetime
- 1999-11-11 PT PT99971702T patent/PT1128819E/pt unknown
- 1999-11-11 EA EA200100538A patent/EA005074B1/ru not_active IP Right Cessation
- 1999-11-11 SK SK625-2001A patent/SK284758B6/sk not_active IP Right Cessation
- 1999-11-11 CZ CZ20011627A patent/CZ299582B6/cs not_active IP Right Cessation
- 1999-11-11 NZ NZ511430A patent/NZ511430A/en not_active IP Right Cessation
- 1999-11-11 CN CNB998132160A patent/CN1169522C/zh not_active Expired - Lifetime
- 1999-11-11 CA CA002350061A patent/CA2350061C/en not_active Expired - Lifetime
- 1999-11-11 US US09/763,281 patent/US6911217B1/en not_active Expired - Lifetime
- 1999-11-11 WO PCT/SE1999/002052 patent/WO2000027364A1/en active IP Right Grant
- 1999-11-11 PL PL99348612A patent/PL195780B1/pl unknown
- 1999-11-11 DK DK99971702T patent/DK1128819T3/da active
- 1999-11-11 EE EEP200100254A patent/EE05232B1/xx unknown
- 1999-11-11 OA OA1200100112A patent/OA11673A/en unknown
- 1999-11-11 UA UA2001042824A patent/UA57165C2/uk unknown
- 1999-11-11 BR BRPI9915142A patent/BRPI9915142B8/pt not_active IP Right Cessation
- 1999-11-11 GE GEAP19995939A patent/GEP20022833B/en unknown
- 1999-11-11 ID IDW00200101038A patent/ID30039A/id unknown
- 1999-11-11 HU HU0105038A patent/HU226582B1/hu unknown
- 1999-11-11 JP JP2000580595A patent/JP3616011B2/ja not_active Expired - Lifetime
- 1999-11-11 EP EP99971702A patent/EP1128819B1/en not_active Expired - Lifetime
- 1999-11-11 MY MYPI99004911A patent/MY122195A/en unknown
- 1999-11-11 KR KR10-2001-7005879A patent/KR100467384B1/ko active IP Right Grant
2000
- 2000-02-11 TW TW089102332A patent/TWI267385B/zh not_active IP Right Cessation
- 2000-02-11 TW TW089102338A patent/TWI222879B/zh not_active IP Right Cessation
2001
- 2001-05-03 ZA ZA200103575A patent/ZA200103575B/en unknown
- 2001-05-09 IS IS5936A patent/IS2370B/is unknown
- 2001-05-10 HR HR20010333A patent/HRP20010333B1/xx not_active IP Right Cessation
- 2001-05-10 NO NO20012314A patent/NO331399B1/no not_active IP Right Cessation
- 2001-06-08 MA MA26228A patent/MA25325A1/fr unknown
- 2001-06-08 BG BG105582A patent/BG65149B1/bg unknown
2002
- 2002-04-04 HK HK02102521.2A patent/HK1040917B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
BG65149B1 (bg)	2007-04-30
AR027815A1 (es)	2003-04-16
SK284758B6 (sk)	2005-11-03
HK1040917A1 (en)	2002-06-28
JP2003517446A (ja)	2003-05-27
NO331399B1 (no)	2011-12-19
BR9915142A (pt)	2001-08-07
ES2204193T3 (es)	2004-04-16
IS2370B (is)	2008-06-15
AU762410B2 (en)	2003-06-26
YU33101A (sh)	2003-10-31
HRP20010333B1 (en)	2004-10-31
PT1128819E (pt)	2003-12-31
GEP20022833B (en)	2002-11-25
CZ299582B6 (cs)	2008-09-10
AP2001002166A0 (en)	2001-06-30
CN1326339A (zh)	2001-12-12
KR100467384B1 (ko)	2005-01-24
HUP0105038A3 (en)	2006-07-28
NO20012314D0 (no)	2001-05-10
RS49891B (sr)	2008-08-07
IS5936A (is)	2001-05-09
KR20010075695A (ko)	2001-08-09
HU226582B1 (en)	2009-04-28
OA11673A (en)	2005-01-12
HUP0105038A2 (en)	2002-06-29
BRPI9915142B8 (pt)	2021-05-25
SE9803871D0 (sv)	1998-11-11
ZA200103575B (en)	2002-05-03
JP3616011B2 (ja)	2005-02-02
EP1128819B1 (en)	2003-08-20
CA2350061C (en)	2005-05-17
BG105582A (en)	2001-12-29
ID30039A (id)	2001-11-01
WO2000027364A1 (en)	2000-05-18
CN1169522C (zh)	2004-10-06
CA2350061A1 (en)	2000-05-18
EP1128819A1 (en)	2001-09-05
HK1040917B (zh)	2005-05-27
PL195780B1 (pl)	2007-10-31
EE05232B1 (et)	2009-12-15
UA57165C2 (uk)	2003-06-16
EA005074B1 (ru)	2004-10-28
CZ20011627A3 (cs)	2001-10-17
TWI222879B (en)	2004-11-01
DE69910604T2 (de)	2004-06-24
EE200100254A (et)	2002-12-16
NO20012314L (no)	2001-07-09
ATE247458T1 (de)	2003-09-15
MA25325A1 (fr)	2001-12-31
TWI267385B (en)	2006-12-01
AP1323A (en)	2004-11-05
AU1436600A (en)	2000-05-29
IL142809A0 (en)	2002-03-10
DE69910604D1 (de)	2003-09-25
BRPI9915142B1 (pt)	2015-08-25
US6911217B1 (en)	2005-06-28
SI1128819T1 (en)	2003-12-31
SK6252001A3 (en)	2002-01-07
MY122195A (en)	2006-03-31
PL348612A1 (en)	2002-06-03
EA200100538A1 (ru)	2001-10-22
NZ511430A (en)	2003-05-30
HRP20010333A2 (en)	2003-04-30

Publication	Publication Date	Title
DK1128819T3 (da)	2003-12-01	Ny kugle til styret frigivelse, fremgangsmåde til dens fremstilling og formulering med flere enheder indeholdende denne
DK0799052T3 (da)	2002-02-25	Ny antihrombotisk formulering, fremgangsmåde til dens fremstilling og anvendelse deraf
HUP0103633A2 (hu)	2002-02-28	Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
NO20012158D0 (no)	2001-05-02	Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK1180518T3 (da)	2007-05-21	5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20004915D0 (no)	2000-09-29	Transdermalt terapeutisk system som inneholder en D2-agonist for behandling av Parkinson-syndromet, og en fremgangsmÕte for dens fremstilling
DK0912194T3 (da)	2004-03-15	Polynucleotid-vaccineformulering, især til behandling af respiratorisk sygdom hos kvæg
DK1117645T3 (da)	2004-08-02	Arylsubstituerede propanolaminderivater, fremgangsmåder til fremstilling deraf, lægemidler indeholdende disse forbindelser og anvendelse deraf
MXPA01005543A (es)	2003-07-14	Formulacion de liberacion controlada que consta de gnrh-ii.
IL146710A0 (en)	2002-07-25	Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
HUP0600141A3 (en)	2008-03-28	Low hygroscopic aripiprazole-anhydrate process for its preparation, pharmaceutical compositions containing it and its use
HUP0200403A3 (en)	2004-07-28	Pyrrolopyrimidines as protein kinase inhibitors, pharmaceutical compositions containing them and their use
IL138280A0 (en)	2001-10-31	20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
NO991815D0 (no)	1999-04-16	Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
HUP0300894A3 (en)	2008-05-28	Substituted beta-carbolines, process for their preparation, pharmaceutical compositions containing them and their use
DK1130968T3 (da)	2003-05-26	Pesticid sammensætning til frøbehandling
DK1261697T3 (da)	2004-11-22	Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
NO20022834D0 (no)	2002-06-14	Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne
DK0791591T3 (da)	2001-10-08	Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
DK0838469T3 (da)	2002-03-18	10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser
NO20003661D0 (no)	2000-07-17	Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
HUP0401369A3 (en)	2006-05-29	Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
ZA200004865B (en)	2001-03-12	Heat transpiration preparation and method of the heat transpiration of chemical by using the same.
IL148514A0 (en)	2002-09-12	Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
DK1064284T3 (da)	2002-07-22	Hypnotiske beta-carbolinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som medicinske produkter